By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

It’s been a busy week at Life Science Nation! As the audience chatters and orchestra buzzes in the moments before curtain opens on a show, the week before Digital RESI November 16-18 has been filled with booking meetings, partnering tutorials, panel planning calls, and putting the finishing touches on pitch materials. The energy is in the air and there’s nothing like it!

Check out some of the content coming to you virtually through Digital RESI November next week. Each session has been carefully crafted to highlight the best in early-stage life science and healthcare, and every feature is designed to connect fundraising founders with investors and strategic partners who are a fit for their product and stage of development.

If you haven’t yet signed up for Digital RESI November, sign up now! There is still time, but meeting slots are booking up fast. If you’re already looking ahead to 2022, sign up for Digital RESI JPM early to save on super early bird rates!

By Caitlin Dolegowski, Marketing Specialist, LSN

Imagine learning critical components to successful fundraising from key experts and deal-makers in a virtual environment specific to early-stage life science and healthcare. It seems too good to be true until you check out the Digital RESI November lineup. Digital RESI November 16-18 offers attendees three days of panels, workshops and pitch sessions, each of which is designed to enrich the journey of early-stage, life science entrepreneurs with insight into what investors are looking for, how CEOs have found success and learning from other fundraising executives. Panel topics have been created to cover hot industry topics, with panelist recruitment focused on adding valuable content for fundraising attendees. Check out the panelists that will be presenting at this November’s conference below.

Partnering has begun for this conference and there is still time to register to attend!

Sangeeta Agarawal Co-Founder & CEO Helpsy Health	Cynthia Cai Venture Partner Viva BioInnovator	Mylea Charvat Principal & Partner LiquidSMARTS	Jonathan Cohen CEO 20/20 GeneSystems
Ruchi Dana Board Member Dana Group	Nissim Darvish Senior Managing Director (Israel) OrbiMed Advisors LLC	Dave Dlesk CEO Embrace Prevention Care	Keren Etkin Founder TheGerontechnologist
Lana Feng Co-Founder & CEO HumaAI Inc	Dave Fogel Member of Screening & Due Diligence Committees Mass Medical Angels	Michael Fossel President and Founder Telocyte	Les Funtleyder Chief Investment Officer TechNik
Shruti Gandhi Founder & Managing Partner Array Ventures	Ernst Geutjes Partner Aglaia Oncology Funds	Tom Gibbs Director Debiopharm Innovation Fund	Kimberly Ha Founder & CEO KKH Advisors
André Harrell Venture Partner Cancer Fund	Chihiro Hosoya BD/VC Head, Rx+ Business Accelerator Astellas Rx+ Business Accelerator	Baudouin Hue Partner Karista	Rachel Stillman, MBA Senior Associate 7wire Ventures
Taha Jangda Partner HealthX Ventures	Yury Kukushkin Investment Director JDRF T1D Fund	Pepper Landson CEO Praetego Inc	Taja Lester Managing Partner Health Equity Capital
Justin Leushner Partner Launchit Ventures	Richard Lipkin Co-Founder, Co-Chair The Catalytic Impact Foundation	Betsabeh Madani Hermann, MBA Life Science and Healthcare Investor and Advisor	Andrew Meadow General Partner Health Innovation Capital
Andy Merken Partner, Corporate and Securities Co-Chair, Life Sciences Burns & Levinson	Brian Meshkin Managing Partner Profound Ventures	Petra Meyer Managing Director – HealthCare Sector Group Lead Golden Seeds	Christos Monovoukas VP, Global M&A/Business Development Olympus Corporation
Alex Morgan Partner Khosla Ventures	Sasha Naydich Associate Myeloma Investment Fund	Rohit Pratap Singh Vice President, Investments Xeraya Capital	Rachel Rea Director of Business Development and Licensing Medtronic
Christina Salys Director of New Business Development Intuitive Surgical	Beth Sanders Founder & CEO LifeBio Inc	Diana Saraceni Founder, Managing Director Panakes Partners	Rachel Scherl CEO SPARK Solutions for Growth
DJ (Dennis) Schmitt Founder/CEO Neuro20 Technologies	Bryan Shao K4 Deal Screening Committee Keiretsu Forum	Xuhui Shao Managing Partner Foothill Ventures	Patrik Sobocki Investment Manager Life Science Industrifonden
Thomas Vogelsong Investor/Life Science Advisor/Director, Deal Flow KYTO Technology and Life Science	Richard Ward Director, Search and Evaluation, Oncology R&D BD AstraZeneca	Travis Whitfill Partner Bios Partners	Thierry Wurch Senior Director Ipsen S.A.
	Tiffany Yu Vice President Equality Asset Management LP	Lu Zhang Managing Partner Fusion Fund

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Life Science Nation’s next event, Digital RESI November, is fast approaching, and with early bird pricing ending this Friday, now is the time to register if you haven’t already. Whether a first-time attendee or a familiar face, RESI offers many opportunities to advance your startup. From panels featuring investors and strategic partners providing insights into how they are best approached, to entrepreneurs sharing their fundraising success stories, to service providers providing tips on how to navigate the complex path to market based on decades of experience, RESI provides opportunities for seasoned entrepreneurs and first-time founders.

What makes RESI truly unique is the match-based partnering infrastructure and free education around how to make the system work in your favor to connect with partners who are a fit for your product and stage of development. RESI’s powerful ability to bring together the early-stage life science ecosystem and to provide companies and investors with a way to tailor their meetings to ensure the most effective use of their time makes it stand out at a time when virtual events are a dime-a-dozen. Don’t believe us? Check out the list of attending investors below. The partnering system is open, so make sure to register soon!

Confirmed Digital RESI November Investors and Strategic Partners

As of October 28